期刊文献+

尖锐湿疣患者皮损Toll样受体8、9的表达 被引量:1

Expressions of TLR8 and TLR9 in lesions of condyloma acuminatum
下载PDF
导出
摘要 目的检测Toll样受体8、9在尖锐湿疣局部皮损中的表达情况,探讨它们在尖锐湿疣发病中的作用,为尖锐湿疣的免疫学发病机制提供可的理论依据。方法采用免疫组化Max vision(即用型快速免疫组化一步法)法检测50例尖锐湿疣皮损和10例正常皮肤(包皮)中TLR8、TLR9的表达情况,并应用IPP6.0彩色图像分析系统进行图像分析定量研究。结果⑴免疫组化定位分析:TLR8在CA皮损中于基底层及棘细胞层强阳性表达,颗粒层及角质层中等强度表达;TLR8在正常表皮基底层弱表达,且以胞质型为主,其他角质形成细胞层及真皮层不表达。TLR9在CA皮损中表皮各层均呈强阳性表达,棘细胞层部分呈颗粒状聚集;TLR9在正常表皮的各层均呈强阳性表达,除角质层外。⑵IPP6.0彩色图像分析定量研究:CA皮损中TLR8和TLR9蛋白表达的相对量分别为0.1267±0.05140和0.1604±0.06153,明显高于正常对照组0.0797±0.02805和0.1263±0.01724,差异均有统计学意义(P<0.05)。结论 TLR8、TLR9在尖锐湿疣患者皮损中的表达较正常对照组明显增强,且集中分布于基底层和棘细胞层。TLR8、TLR9可能是HPV的识别受体,参与机体局部皮损抗HPV免疫应答。 Objective To explore the role of TLR8 and TLR9 on the pathogenesis of condyloma acuminatum(CA) through detecting the expressions of TLR8 and TLR9 on skin lesions,and provide reference theory basis in the immunological pathogenesis of CA. Methods An immunohistochemical method using Max vision(Ready-to-use immunohistochemical one-step quickly) was performed to detect the expressions of TLR8 and TLR9 in tissue specimens obtained from the CA lesions of 50 patients and from the foreskin of 10 normal human controls. Results In normal skin samples,there was a week expression of TLR8 in the stratum basale,and in the cytoplasm-based,but a negative expression in keratinocytes of almost all epidermal layers except for stratum basale. In contrast,a strong expression of TLR8 in the stratum basale and stratum spinosum,medium expression in the stratum corneum and stratum granulosum in CA lesions. In normal skin samples,TLR9 was strong positive expression in almost all epidermal layers except for stratum corneum,and in the CA lesions,TLR9 was strong expression in all epidermal layers,some particle aggregation. The second,IPP6.0 color image analysis of quantitative research:in the CA lesions,the relative amounts of protein expression of TLR8 and TLR9 are 0.1267 ±0.05140 and 0.1604 ±0.06153 was significantly higher than that in normal foreskins 0.0797±0.02805 and 0.1263±0.01724(all P〈0.05). Conclusion The expressions of TLR8 and TLR9 are markedly enhanced in CA lesions compared with normal skin,which may be served as recognition receptors for HPV infection.and involved in the body's anti-HPV immune response.
出处 《江西医药》 CAS 2015年第8期763-766,共4页 Jiangxi Medical Journal
关键词 尖锐湿疣 TOLL样受体 人乳头瘤病毒 Condyloma acuminatum Toll-like receptors Human papillomavirus
  • 相关文献

参考文献12

  • 1赵辨.中国临床皮肤病学【M】.第4版.南京:江苏科学技术出版社.2012.1816—1821.
  • 2IBowie AG,Haga IR. The rule of Toll-like reeeph)rs in the host response to viruses[J]. Mol lmmuno],2005,42(8):859-867.
  • 3ILatz E,Sehuenemeyer A,Visintin A,et a[. TI,R9 signals after translucating from the ER to CpG DNA in the lysosome [J]. Nat lmmunol, 2004,5(2) : 190-198.
  • 4Kawai T,Akira S. The rule of pattern-recognition receptors in innate immunity:update on Toll-like reeeptoJ:'; [.J]. Nature lmmunnlogy ,2010,11(5) :373-384.
  • 5Gregol~' M Barton,Jonathan C Kagan, RuslanMedzhituv. Intraeellu lar localization of Toll-like receptor 9 prevents recognition of self DNA but facilitate access to vital I)NA [J], J Nature hnmunology, 2006,7(1) : 49-56.
  • 6Hu X,Chen J,Wang L.et al. Crusstalk among JakSTAT,Toll-like receptor and ITAM-dependent path-ways in maerophage activati on[J]. J Leukoc Bio,2007,82(2):237-243.
  • 7Boo KH,Yang JS. hltrinsie cellular defenses against virus infeetiuu by antiviral type I interferon[J]. Yonsei Med J,2010,51(1):9-17.
  • 8茅晓红,张巍巍,陈贤祯,程浩.Toll样受体在尖锐湿疣皮损中的表达[J].中华皮肤科杂志,2010,43(9):637-640. 被引量:8
  • 9王建琴,莫友,吴伟棋,方锐华,许剑荣,杨捷,唐绍生,魏亚明.尖锐湿疣患者皮损Toll样受体4、9和C型凝集素受体的表达[J].中华皮肤科杂志,2011,44(5):318-321. 被引量:12
  • 10张悦,董冠英,韩秀萍.不同预后尖锐湿疣组织中Toll样受体3、9的表达[J].中华皮肤科杂志,2011,44(5):354-356. 被引量:5

二级参考文献41

  • 1张建成,丁怡,周总光,李红光,周斌.人乳头状瘤病毒16 E7 DNA在结直肠腺癌组织中的表达[J].生物医学工程学杂志,2005,22(5):1024-1026. 被引量:3
  • 2李圆圆,王玉坤,郝宝珍.尖锐湿疣、鲍恩样丘疹病、Bowen病及外阴鳞状细胞癌皮损中端粒酶的表达[J].中华皮肤科杂志,2006,39(5):266-268. 被引量:5
  • 3Dursun P,Senger SS,Arslan H,et al.Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit.BMC Infect Dis,2009,9:191.
  • 4McInturff JE,Modlin RL,Kim J.The role of toll-like receptors in the pathogenesis and treatment of dermatological disease.J Invest Dermatol,2005,125(1):1-8.
  • 5Chen XZ,Mao XH,Zhu KJ,et al.Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.Arch Dermatol Res,2010,302(1):57-65.
  • 6Ku JK,Kwon HJ,Kim MY,et al.Expression of Toll-like receptors in verruca and molluscum contagiosum.J Korean Med Sci,2008,23(2):307-314.
  • 7Bowie AG,Haga IR.The role of Toll-like receptors in the host response to viruses.Mol Immunol,2005,42(8):859-867.
  • 8Le Poole C,Denman CJ,Arbiser JL.Immunosuppression may be present within condyloma acuminata.J Am Acad Dermatol,2008,59 (6):967-974.
  • 9Santegoets LA,van Seters M,Heijmans-Antonissen C,et al.Reduced local immunity in HPV-related VIN:expression of chemokines and involvement of immunocompetent cells.Int J Cancer,2008,123(3):616-622.
  • 10Hasan UA,Bates E,Takeshita F,et al.TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.J Immunol,2007,178(5):3186-3197.

共引文献29

同被引文献38

  • 1Gross G.Genitoanal human papillomavirus infection and associated neoplasias[J].CurrProbl Dermatol,2014,45:98-122.
  • 2Connolly DJ,O’Neill LA.New developments in Toll-1ike receptor targeted therapeutics[J].Current Opinion in Pharmacology,2012,12(4):510-518.
  • 3Kim SJ,Choi Y,Choi YH,et al.Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice[J].Nutr Biochem,2012,23(2):113-122.
  • 4Karin E.Finberg.Ironing out the role of Toll-like receptors[J].Blood,2015,125(14):2183-2184.
  • 5Song DH,Lee JO.Sensing of microbial molecular patterns by Tolllike receptors[J].Immunol Rev,2012,250(1):216-229.
  • 6Alexis Vandenbon,Shunsuke Teraguchi.Systems biology approaches to toll-like receptor signaling[J].Wiley Interdiscip Rev SystBiol Med,2012,4(5):497-507.
  • 7O'Neill,Golenbock D,Bowie AG.The history of Toll-like receptors-redefining innate immunity[J].Nat Rev Immunol,2013,13(6):453-460.
  • 8Lee CC,Avalos AM,Ploegh HL.Accessory molecules for Tolllike receptors and their function[J].Nat Rev Immunol,2012,12(3):168-179.
  • 9Kaisho T.Pathogen sensors and chemokine receptors in dendritic cell subsets[J].Vaccine,2012,30(52):7652-7657.
  • 10Dunne A,Marshall NA,Mills KH.TLR based therapeutics[J].Current Opinion in Pharmacology,2011,11(4):404-411.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部